Preliminary Program

Preliminary Program
 Thursday, 22 February, 2018 
14:00-18:00Registration 
18:00-19:00Welcome ReceptionExhibition Area
   
  Friday, 23 February, 2018 
   07:30    Registration 
09:00-11:10Plenary Session 1: Opening Session
Chairs: Stevo Julius, USA, Reuven Zimlichman, Israel
 Hall A
   09:00      Greetings 
09:10Sympathetic Overdrive and the Metabolic Syndrome in Prehypertension Pathophysiology of Obesity and Insulin Resistance in Prehypertension
Stevo Julius, Division of Cardiovascular Medicine, Internal Medicine and Physiology, University of Michigan, Ann Arbor, MI, USA
 
   09:40    Prehypertention: Past, Present, Future
Reuven Zimlichman, Sackler Faculty of Medicine, Tel Aviv University, The E. Wolfson Medical Center, Holon, Israel
 
 10:10Metabolic Syndrome and Microcirculation
Enrico Agabiti-Rosei, Dept of Medical and Surgical Sciences, University of Brescia, Italy
 
    10:40   Role of the Kidney in the Early Stages of Hypertension 
Hermann Haller, Dept. of Nephrology and Hypertension Medicine, University of Hannover, Hannover Medical School, Germany
 
11:10-11:40Coffee Break, Exhibition Visit and Posters ViewingExhibition Area
11:40-13:40 Plenary Session 2: Prehypertnsion - Challenge and Approach
Chairs: Rhian Touyz, UK, Alberto Zanchetti, Italy
Hall A
   11:40    Global Hypertension – Challenges and Opportunities
Rhian Touyz, UK
 
    12:10    The Renin-Angiotensin-Aldosterone System in Prehypertension: Pathology and Intervention
Thomas Unger, CARIM - School for Cardiovascular Diseases, Maastricht University, The Netherlands
 
    12:40    When should Individuals with High-Normal and Normal Blood Pressure Receive Blood Pressure-Lowering Treatment?
Alberto Zanchetti, Italy 
 
    13:10    How to Optimize Cardiovascular Risk Management in Hypertension. Evidence from Recent Meta- Analyse 
Gianfranco Parati, Cardiology Unit, S. Luca Hospital, Istituto Auxologico Italiano, Milan and Dept. of Medicine and Surgery, University of Milano-Bicocca, Italy
 
13:40-14:30Lunch Break, Exhibition Visit and Posters Viewing 
14:30-16:10Plenary Session 3: Prehypertension - Estimation of Risk and Mechanisms
Chairs: Daniel A Duprez, USA, Andrzej Januszewicz, Poland
Hall A
 14:30Markers of Fibrosis - Aging and the Cardovascular System, Blood Pressure – and Statin Therapy 
Daniel A. Duprez, Cardiovascular Division, University of Minnesota, Minneapolis, MN, USA 

 
 14:50

Device Therapy for the Treatment of Resistant Hypertension 
John R. Cockroft, Wales Heart Research Institute, University Hospital Cardiff, UK         

 
  15:10Is Prehypertension a Risk Factor for Cardiovascular Disease? 
Andrzej Januszewicz, Dept. of Hypertension, Institute of Cardiology, Warsaw, Poland
 
  15:30

Polygenic Risk Score as a New Tool for Early Decisions in Cardio-  Metabolic Syndrome
Pavel Hamet, University of Montreal and Dept. of Experimental Medicine at McGill University, Canada   

 
  15:50How far blood pressure should be lowered in high risk hypertensive patients 
Athanasios J. Manolis, Director, Department of Cardiology "Asklepeion" General Hospital, Athens
 
 14:30-16:10 Parallel Session 1: Research Presentations
Chairs: TBA
 Hall B
   14:30Abstract Presenter 
   14:50 Abstract Presenter 
   15:05 Abstract Presenter 
   15:25 Abstract Presenter 
   15:40Abstract Presenter 
   15:55Abstract Presenter 
     
16:10-16:40Coffee Break, Exhibition Visit and Posters ViewingExhibition Area
16:40-18:40Plenary Session 4: Prehypertension- Mechanistic Approach
Chairs: Dagmara Hering, Poland, Paolo Palatini, Italy
 Hall A
   16:40 Evidence for Increased Sympathetic Activation in Prehypertension
Dagmara Hering, Dept. of Hypertension and Diabetology, Medical University of Gdansk, Poland  
 
   17:10 Arterial Distensibility, Physical Activity and the Metabolic Syndrome
Paolo Palatini, Dept. of Medicine, Vascular Medicine, University of Padova, Italy 
 
   17:40 Short Sleep Time – a Modifiable Risk Factor for Prehypertension and Hypertension?
Aleksander Prejbisz, Dept. of Hypertension, Institute of Cardiology, Warsaw, Poland
 
   18:10 New Strategies to Preserve Renal Function in Kidney Disease
Bruno Watschinger, Dept. of Medicine, University of Vienna Medical School, Vienna, Austria
 
   
 Saturday, 24 February, 2018 
   07:30 RegistrationExhibition Area
 08:30-09:50Plenary Session 5: Inflammatory Mechanisms and Prehypertension 
Chairs: Damiano Rizzoni, Italy, Talma Rosenthal, Israel
 Hall A
   08:30 Immune System and Microvascular Alterations in Obesity and Hypertension
Damiano Rizzoni, Dept. of Medical and Surgical Sciences, University of Brescia, Italy 
 
   08:50Detecting the Risk of Prehypertention, via Pathological Inflammatory Markers
Talma Rosenthal, Sackler Faculty of Medicine, Tel Aviv University, Israel
 
   09:10

Arterial Biomarkers in Prehypertension
Charalambos Vlachopoulos, 1st Department of Cardiology, University of Athens Medical School, Greece

 
   09:30Evidence for Increased Risk of Induced Atherosclerosis, Including Subclinical Forms in Autoimmune Disease: The Key to the Success is Multidisciplinary Approach
Ljudmila Stojanovich, Scientific Research Dept. Bezhanijska Kosa, University Medical Center, Belgrade University, Serbia 
 
09:50-10:20Coffee Break, Exhibition Visit and Posters ViewingExhibition Area
10:20-12:20Plenary Session 6: Prehypertension, Development and Contribution of Studies
Chairs: John R. Cockroft, UK, Guido Grassi, Italy
Hall A
   10:20 Prehypertension in the PAMELA Study: Results and Perspectives
Guido Grassi, Dept of Internal Medicine, University of Milano Biocca, Milan, Italy
 
   10:40 Hemodynamics of Prehypertension 
Peter W. de Leeuw, Dept of Medicine University Hospital Maastricht, The Netherlands
 
   11:00Prehypertension: an Advanced Stage of Abnormal Blood Pressure Increasing with Age
Flávio D. Fuchs, Hospital de Clinicas de Porto Alegre, Brazil   
 
   11:20 What we Learnt with the PREVER-PREVENTION Trial? 
Sandra Fuchs, Hospital de Clinicas de Porto Alegre, Brazil 
 
   11:40 Diurnal and Pulsatile Hemodynamics in Prehypertension
Thomas Weber, Dept. of Cardiology, Klinikum Wels-Grieskirchen, Wels, Austria
 
   12:00 What can we Learn from the Observational Studies and Clinical Trials of Prehypertension?
Yuqing Zhang, Division of Hypertension, Fu Wai Hospita, Beijing, China
 
 12:20-13:20 Lunch Break, Exhibition Visit and Posters Viewing 
 13:20-15:00Plenary Session 7: Prehypertension and Diabetes
Chairs: Efrain Reisin, USA, Guntram Schernthaner, Austria 
 Hall A
   13:20Obesity and Hypertension in Chronic Kidney Disease or Systolic Hypertension: The Heart and the Kidney
Efrain Reisin, Dept. of Nephrology and Hypertension, Louisiana State University Health Science Center, New Orleans, LA, USA 
 
   13:40 Masked Hypertension in Diabetes Mellitus
Michael Bursztyn, Department of Medicine, Hypertension Unit Hadassah-Hebrew University Medical Center, Mount-Scopus, Jerusalem, Israel
 
   14:00 Influence of Insulin Resistance and Hyperinsulinism on Heart Rate Variability, Myocardial Strain and Arterial Stiffness
Salvatore Novo, Dept. of Internal Medicine and Cardiovascular Disease, University of Palermo, Italy
 
   14:20 Treating Hypertension in Patients with Type 2 Diabetes
Brian Rayner, Division of Nephrology & Hypertension, University of Cape Town, South Africa
 
   14:40Clinical Relevance of Blood Pressure Lowering Effect of Modern Antidiabetic Drugs
Guntram Schernthaner, Dept. of Medicine I, Rudolfstiftung Hospital, Vienna, Austria
 
 15:00-16:20Plenary Session 8: Prehypertension and Age Groups
Chairs: Bojan Jelakovic, Croatia, Ian B. Wilkinson, UK
 Hall A
   15:00 Markers of Early Cardiovascular Dysfunction in Prehypertension - Difference Between Youth and Elderly
Bojan Jelakovic, University of Zagreb School of Medicine, University Hospital Center Zagreb, Croatia   
 
   15:20 Prehypertension in Children and Adolescents – an Overwiew
Mieczysław Litwin, Dept. of Nephrology and Arterial Hypertension, The Children’s Memorial Health Institute, Warsaw, Poland
 
   15:40 Why Treat Young People with Borderline Hypertension?
Ian B. Wilkinson, Clinical Pharmacology Unit, Addenbrooke’s Hospital, Cambridge, UK 
 
   16:00 Prehypertension and Metabolic Syndrome in Different Populations – Epidemiology
Cetin Erol, Ankara University, Faculty of Medicine, bn-i Sina Hospital, Dept. of Cardiology, Ankara, Turkey
 
 16:20-16:45 Coffee Break, Exhibition Visit and Posters ViewingExhibition Area
 16:45-18:00Plenary Session 9: Prehypertension and the Heart
Chairs: Bojan Jelakovic, Croatia, Ian B. Wilkinson, UK
 Hall A
   16:20 Predictive Value of CAC Progression for Coronary and CV Events in Prehypertension Most Recent CT Scan Overrides CAC Progression in Coronary and CV
Raimund Erbel, Dept.of Cardiology, West German Heart Centre Essen, Division of Internal Medicine, University Essen, Germany
 
   16:40 The Hypertensive Patient with Angina: Tips and Tricks in Management
Giuseppe Ambrosio, Dept. of Cardiology, University of Perugia School of Medicine, Perugia, Italy
 
   17:00 Threshold Level of Exercise Systolic Blood Pressure at Moderate Workload in Predicting Coronary Heart Disease in Healthy Middle-aged Men
Sverre E. Kjeldsen, Dept. of Cardiology, University of Oslo Ullevaal Hospital, Norway
 
   17:20 Clinical Importance of Exercise Capacity as a Determinant of Cardiovascular Health
Arno Schmidt-Trucksaess, Division Sports and Exercise Medicine, Medical Faculty, University Basel, Switzerland
 
   17:40 How to Undertake the Sub Typing of Primary Aldosteronism?
CT- strategy?
AVS strategy?
Functional imaging?
Gian Paolo Rossi, Dept. of Medicine, University of Padova, Italy
 
 20:00-22:30Gala Dinner (Optional) Hall A
   
 Sunday, 25 February, 2018 
   07:30 RegistrationExhibition Area
 08:30-10:30 Plenary Session 10: Management of Prehypertension and Hypertension in Women of Childbearing Age
Chairs: Renata Cifkova, Czech Republic, Danuta Czarnecka, Poland
 Hall A
   08:30 Prehypertension and Hypertension in Pregnancy
Renata Cifkova, Czech Republic
 
   09:00 Hypertensive Disorders of Pregnancy – Do they Influence Future Cardiovascular Health of Mother or Children?
Katarzyna Stolarz-Skrzypek, Poland
 
   09:30 Diagnostic Workup and Treatment Strategies for Prehypertension in Women of Childbearing Potential
Agnieszka Olszanecka, Poland
 
   10:00 Should Hypertensive Disorders of Pregnancy be Considered as a Prehypertension State 
Jack Blacher
 
   10:30 Haemodyanics of Pregnancy Associated Hypertension
John R. Cockroft, Wales Heart Research Institute, University Hospital Cardiff, UK
 
   
 11:00-11:30Coffee Break, Exhibition Visit and Posters ViewingExhibition Area
11:30-13:00Closing Session 11: Summary
Chairs: Stevo Julius, USA, Reuven Zimlichman, Israel
Hall A
11:30 The Potential Importance of Antihypertensive Properties of Non-antihypertensive Drugs in Patients with Prehypertension
Marcin Adamczak, Dept. of Nephrology, Transplantation and Internal Medicine, Medical University of Silesia, Poland
 
11:50 Patient Oriented Prevention of Cardiovascular Complications : New Targets ,New Diagnostic Tools, New Treatments (Hyperlipidemia , Inflammation, Hypertension and More..) 
Dov Gavish, Medicine A Wolfson Hospital, Sackler Faculty of Medicine Tel Aviv University, Israel
 
12:10 Artificial intelligence and hypertension: new approach in understanding of possible mechanisms
Branislav Milovanovic, Serbia
 
12:30Summary
Stevo Julius, USA, Reuven Zimlichman, Israel